Back
Cytokinetics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
CYTK
Cytokinetics, Inc.
Last Price:
$66.55
Seasonality Move:
9.68%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCytokinetics, Inc. Stock Forecast
-
Over the next 52 weeks, Cytokinetics, Inc. has on average historically risen by 12.4% based on the past 21 years of stock performance.
-
Cytokinetics, Inc. has risen higher in 9 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Cytokinetics, Inc. Stock Undervalued?The current Cytokinetics, Inc. [CYTK] share price is $66.54. The Score for CYTK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cytokinetics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cytokinetics, Inc. has on average historically risen by 12.4% based on the past 21 years of stock performance.
Cytokinetics, Inc. Stock Rating
Sell
44
Cytokinetics, Inc. (CYTK)
is a Sell
Is Cytokinetics, Inc. overpriced?
-
Cytokinetics, Inc. has risen higher in 9 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Cytokinetics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
69.33
52-Week Low:
29.31
Prediction Charts
Market Cap:
8.1B
Price in USD:
66.54
Volume:
1.5M
Beta:
1.44
Technical Analysis
SMA50:
61.22
SMA100:
51.33
SMA200:
44.51
52-Wk Change:
31.92%
Stock Predictions
-
Is Cytokinetics, Inc. stock public?Yes, Cytokinetics, Inc. is a publicly traded company.
-
What is the Cytokinetics, Inc. stock quote today?The Cytokinetics, Inc. stock price is 66.54 USD today.
-
How to buy Cytokinetics, Inc. stock online?You can buy Cytokinetics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 64.11 | 66.44 | 67.07 | 64.11 |
| Nov-17 | 66.01 | 66.95 | 67.98 | 65.33 |
| Nov-18 | 66.45 | 66.16 | 67.80 | 66.00 |
| Nov-19 | 65.39 | 64.79 | 65.91 | 63.70 |
| Nov-20 | 65.38 | 63.50 | 65.66 | 62.86 |
| Nov-21 | 63.46 | 65.44 | 66.76 | 63.02 |
| Nov-24 | 65.50 | 67.21 | 67.55 | 64.80 |
| Nov-25 | 66.86 | 67.55 | 67.72 | 66.00 |
| Nov-26 | 67.95 | 68.15 | 68.91 | 67.50 |
| Nov-28 | 68.60 | 68.13 | 69.33 | 67.71 |
| Dec-1 | 67.89 | 66.05 | 67.99 | 65.92 |
| Dec-2 | 65.85 | 63.51 | 65.85 | 62.58 |
| Dec-3 | 63.69 | 64.66 | 65.51 | 63.59 |
| Dec-4 | 64.06 | 66.54 | 67.26 | 63.50 |
Cytokinetics, Inc. Earnings
Cytokinetics, Inc. Earnings Report: Per Share Cytokinetics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics, Inc. Forecast Revenue Growth
Cytokinetics, Inc. Stock Analysis: Historical quarterly revenues per share for Cytokinetics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.01 per share.
* Cytokinetics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.